Market Share of Biomarkers Industry
The biomarkers market is moderately competitive. The growth of this market is majorly dependent on the advancement in technology and investment in R&D. Most pharmaceutical companies are investing in R&D, and governments are also spending a considerable sum of money on the progress of technology, which is anticipated to drive market growth. Some of the key players in the market include Abbott Laboratories Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Epigenomics AG, and Qiagen.
Biomarkers Market Leaders
-
Johnson & Johnson
-
Bio-Rad Laboratories
-
Epigenomics AG
-
Qiagen
-
F. Hoffmann-La Roche Ltd
*Disclaimer: Major Players sorted in no particular order
